Skip to main content
. 2020 Jul 31;20:14–19. doi: 10.1016/j.euros.2020.06.007

Table 2.

Patient responses to PCS12 and MCS12 at baseline and follow-up surveys

Mean 95% CI p value
PCS12
 Before 40.4 39.4–41.4 <0.0001
 After 36.8 35.7–37.8
MCS12
 Before 52.3 51.4–53.2 0.0003
 After 49.9 48.9–50.9

CI = confidence interval; MCS12 = composites scores for mental health; PCS12 = composites scores for physical health.

PCS12 and MCS12 were significantly lower at follow-up (after bladder cancer) than at baseline (before bladder cancer).